Lungenpraxis Hohenzollerndamm Research Center for Medical Studies

The Lungenpraxis Hohenzollerndamm Research Center conducts focused respiratory tract disease research, primarily addressing severe forms of asthma.

• Evaluation of Verekitug (UPB-101) for reducing asthma attacks
• Long‑term safety monitoring of dexpramipexole in eosinophilic asthma
• Improving outcomes for patients with severe asthma

Patients with severe asthma or severe eosinophilic asthma can participate in studies that test new therapies and assess ongoing safety, with the research conducted at the Berlin‑based centre under a single dedicated investigator.